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Abstract
The DNA demethylase TET1 is highly expressed in embryonic stem cells and is important both for lineage
commitment, and reprogramming to naïve pluripotency. TET1 interacts with the pluripotency transcription
factor NANOG which may contribute to its biological activity in pluripotent cells. However, how TET1 inter-
acts with other proteins is largely unknown. Here, we characterise the physical interaction between TET1
and NANOG using embryonic stem cells and bacterial expression systems. TET1 and NANOG interact
through multiple binding sites that act independently. Critically, mutating conserved hydrophobic and aro-
matic residues within TET1 and NANOG abolishes the interaction. On chromatin, NANOG is predomi-
nantly localised at ESC enhancers. While TET1 binds to CpG dinucleotides in promoters using its
CXXC domain, TET1 also binds to enhancers, though the mechanism involved is unknown. Comparative
ChIP-seq analysis identifies genomic loci bound by both TET1 and NANOG, that correspond predomi-
nantly to pluripotency enhancers. Importantly, around half of NANOG transcriptional target genes are
associated with TET1-NANOG co-bound sites. These results indicate a mechanism by which TET1 protein
may be targeted to specific sites of action at enhancers by direct interaction with a transcription factor.
 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecom-
mons.org/licenses/by/4.0/).Introduction
Ten-eleven-translocation (TET) family proteins
are responsible for active DNA demethylation by
oxidation of 5-methylcytosine1,2 and play important
roles during embryonic development and various
physiological processes.3 TET proteins contribute
to DNA demethylation in naïve embryonic stem
cells (ESCs),4–7 in particular at enhancers.8–13
TET protein activity is required both for proper dif-
ferentiation14,15 and reprogramming to pluripo-
tency.16–18 TET1 is the most highly expressed
TET family protein both in pluripotent cells and dur-
ing early development.19–21 TET1 predominantly
binds to promoters via its N-terminal CXXC domain
which recognises unmethylated CpG dinu-
cleotides.22–25 TET1 binding at enhancers inrs. Published by Elsevier Ltd.This is an open accESCs26–28 could be mediated by interactions with
the pluripotency factors NANOG, PRDM14, OCT4
and SOX2.29–32 Interestingly, co-expression of
TET1 and NANOG in pre-iPS cells synergistically
enhances reprogramming to pluripotency.29 How-
ever, how TET1 might be recruited to chromatin
via protein–protein interactions remains poorly
understood with little known about the residues
involved in protein binding.
Here, the interaction between TET1 and the
pluripotency factor NANOG was characterised in
ESCs. Co-immunoprecipitations using an array of
TET1 truncations and mutants uncovered novel
regions involved in protein–protein interactions,
both within and outwith the well characterised
catalytic domain. Furthermore, alanine
mutagenesis identified single residues that showess article under the CC BY license (http://creativecommons.org/licenses/
Journal of Molecular Biology (2020) xxx, xxx–xxx
6076 The TET1-NANOG interaction in embryonic stem cellshigh evolutionary conservation and that contribute
to the interaction of TET1 with NANOG.
Comparison of TET1 and NANOG ChIP-seq
datasets identified genomic loci that are putatively
regulated by the TET1-NANOG complex.
Results
The TET1 N-terminus interacts directly with
NANOG via the evolutionary conserved
residues L110 and L114
The TET1 protein expressed in mouse ESCs is
composed of 2039 residues. TET1 is
characterised by an evolutionary conserved C-
terminal catalytic domain, that can be subdivided
into a cysteine rich region (residues 1367–1550)
and a double stranded beta helix domain (DSBH)
(residues 1551–2039) (Figure S1(a)). TET1 also
possesses a CXXC domain (residues 567–608), a
DNA binding region.33 NANOG is a 305 amino
acids transcription factor comprising a N-terminal
domain (residues 1–95), a DNA binding home-
odomain (residues 96–155) and a C-terminal
region containing a tryptophan-repeat (WR) (resi-
dues 199–243) (Figure S1(a)). TET1 has been
identified as a NANOG-binding protein by indepen-
dent affinity purification-mass spectrometry analy-
ses.29,30 We therefore analysed the interaction
between endogenous TET1 and NANOG in
pluripotent cells using nuclear protein extracts from
Tet1-(Flag)3 ESCs
21 immunoprecipitated with an
anti-Flag antibody. Relative to controls from
E14Tg2a ESCs which showed only background
binding, FLAG immunoprecipitates from Tet1-
(Flag)3 ESCs were strongly enriched for NANOG
(Figure S1(b)). This confirms that NANOG and
TET1 proteins interact in ESCs when expressed
at endogenous levels. Notably, TET1 protein in
immunoprecipitates migrates slower than input
material on immunoblots; a phenomenon previ-
ously reported.34–36 Next, to determine whether
TET1 interacts with NANOG via the TET1 N- or
C-terminus, two large (Flag)3-tagged TET1 frag-
ments 1–631 and 734–2039 were cloned and
expressed in ESCs (Figure 1(a)), together with
NANOG. Following TET1 immunoprecipitation,
NANOG was co-immunoprecipitated with both con-
structs (Figure 1(b)). As TET1 1–631 and 734–
2039 do not contain overlapping residues, these
results suggest that TET1 contains at least two
NANOG-interacting domains (NIDs) that function
independently.
To begin to explore how NANOG binds to the
TET1 N-terminus, (Flag)3-tagged TET1 fragments
1–321, 1–215 and 1–108 were cloned and
expressed in ESCs (Figure S1(c)), together with
NANOG. NANOG was co-immunoprecipitated
with TET1(1–321) and TET1(1–215) but not TET1
(1–108) (Figure S1(d)). To home in on the
NANOG-interacting domain within the TET1
N-terminus and to determine whether theinteraction between the TET1 N-terminus and
NANOG was direct, both (His)6-tagged NANOG
and several MBP-tagged TET1 fragments (1–321,
1–215, 1–165, 1–120, 1–108) were cloned into
IPTG-inducible plasmids and expressed in
Escherichia coli (Figure 1(c)). MBP-TET1
fragments purified using an amylose resin were
examined for co-purifying NANOG by
immunoblotting. NANOG co-purified with all TET1
fragments, except TET1(1–108) which showed a
dramatically decreased interaction with NANOG
(Figure 1(d)). Importantly, these experiments
confirmed a direct physical interaction and
narrowed down the first NANOG-interacting
domain (NID 1) to 11 residues (109–120). Protein
alignments showed that NID 1 is highly conserved
among mammals, indicating a selective pressure
for the conservation of these TET1 residues
(Figure S1(e)). However, residues 109–120 of
TET1 do not align with TET2 or TET3 proteins
(data not shown). To identify which residues are
responsible for binding to NANOG, the MBP-TET1
1–120 plasmid construct was modified by alanine
substitution of specific amino acids (proline,
glutamine, arginine, leucine, serine and valine)
within residues 109–120 (Figure 1(e)). The
binding of NANOG to each mutant construct was
assessed following bacterial expression and TET1
purification. Strikingly, only the L?A mutant
(L110A, L114A) showed a decreased interaction
with NANOG, which was reduced to a similar
extent as the negative control TET1 1–108
(Figure 1(f)). Together, these data indicate that
one or both of the two evolutionary conserved
leucine residues (L110 and/or L114) are in direct
physical interaction with NANOG.
To determine which regions of NANOG interact
directly with the TET1 N-terminus, MBP-TET1 1–
321 was co-expressed with several (His)6-tagged
NANOG truncations in E. coli (Figure 2(a)).
Surprisingly, the TET1 N-terminus interacted with
three out of four NANOG truncations: 1–160,
91–246, and 194–305 (Figure 2(b)). However, the
TET1 N-terminus showed no interaction with the
NANOG homeodomain (Figure 2(b)). Moreover,
while the NANOG WR interacts with MBP-SOX2
(positive control30), MBP-TET1 1–321 showed no
physical interaction with the NANOG WR
(Figure S2). Collectively, these results indicate that
the TET1 N-terminus interacts with several inde-
pendent sites on NANOG, and independently of
its two most characterised domains: the home-
odomain and the WR (Figure 2(c)).
The TET1 C-terminus contains two domains
that bind NANOG via aromatic interactions
Following the initial observation that TET1
contains >1 independent NANOG-interacting
domains (Figure 1(b)), the TET1 C-terminus was
analysed to identify the NANOG-interacting
residues. Regions of TET1 extending from 734 to
Figure 1. TET1 contains independent NANOG-binding regions. (a) and (b) Co-immunoprecipitations of non-
overlapping (Flag)3-TET1 N- and C-terminal constructs (a) with (HA)3-NANOG from E14/T ESCs. (b) Immunoblots
were probed with the antibodies indicated on the left (representative images, n = 2). (c) and (d) Co-purification of MBP-
tagged TET1 N-terminal constructs with (His)6-NANOG from E. coli. (c) Fragments of the TET1 N-terminus are shown
in the context of full length TET1. (d) Immunoblots were probed with the antibodies indicated on the left (representative
images, n = 3). (e) and (f) Co-purification of (His)6-NANOG with alanine substitution mutants of MBP-TET1 (1–120)
from E. coli. (e) Alanine substitution mutants of TET1 (109–120) are shown in the context of full length TET1. (f)
Immunoblots were probed with the antibodies indicated on the left (representative images, n = 3).
6077The TET1-NANOG interaction in embryonic stem cellsvarying degrees towards the Cys domain were
expressed together with NANOG in ESCs
(Figures 3(a) and S3(a)). TET1 fragments
containing truncations up to residue 1181 (734–1229, 734–1202, 734–1181) were able to bind
NANOG, while further C-terminal truncations
(734–1155 and 734–1131) abolished interaction
with NANOG (Figure S3(a) and (b)). Analysis of a
Figure 2. Multiple NANOG regions interact with the TET1 N-terminal domain. (a) and (b) Co-purification of MBP-
TET1 1–321 with (His)6-NANOG constructs (a) from E. coli. (b) Immunoblots were probed with the antibodies indicated
on the left (representative images, n = 2). (c) Diagram of the interactions between the TET1 NID 1 and NANOG,
highlighting critical leucines (red). Dashed arrows indicate potential TET1-interacting regions in NANOG.
6078 The TET1-NANOG interaction in embryonic stem cellsfurther truncation (734–1169) narrowed down the
second NANOG-interacting domain of TET1 to
residues 1156–1169 (NID 2) (Figure 3(a) and (b)).
A construct containing NID 2 did not interact with
NANOG when co-expressed in E. coli (Figure S3(c) and (d)) suggesting that either the interaction
observed in ESCs is indirect, or that a direct
interaction dependent on post-translational
modifications and/or protein folding could not be
reproduced in bacteria. However, this interaction
Figure 3. The NANOG interaction domain 2 of TET1 binds NANOG using phenylalanine residues. (a) and (b) Co-
immunoprecipitation of the (Flag)3-TET1 constructs (a) with (HA)3-NANOG from E14/T ESCs. (b) Immunoblots were
probed with the antibodies indicated on the left (representative images, n = 3). (c) and (d) Co-immunoprecipitation of
alanine substitution mutants of (Flag)3-TET1(734–1169) with (HA)3-NANOG from E14/T ESCs. (c) Alanine
substitutions of the amino acids within residues 1156–1169. (d) Immunoblots were probed with the antibodies
indicated on the left (representative images, n = 2).
6079The TET1-NANOG interaction in embryonic stem cellsdoes not depend on phosphorylation. While
treatment of ESC protein extracts with
phosphatase affected the mobilities of both TET1
and NANOG proteins, TET1(734–1169) retained
the capacity to bind NANOG (Figure S3(e)).
Residues 1156–1169 of mouse TET1 (NID 2)
have a high similarity to sequences of TET1
proteins from other mammals, with phenylalanine
1158 strictly conserved (Figure S3(f)). This region
did not align with TET2 or TET3 proteins (data not
shown). To identify residues that bind NANOG,
the expression plasmid encoding TET1 734–1169
was modified by alanine substitution of specific
amino acids (proline, phenylalanine, leucine and
isoleucine) within residues 1156–1169 (Figure 3
(c)). The F?A mutant (F1158A, F1168A) was the
only mutant that showed a decreased interactionwith NANOG (Figure 3(d)). Together, these results
indicate that phenylalanine 1158 and/or 1168 are
critical for NANOG binding.
The preceding results identified two independent
NANOG-interacting domains within residues 109–
120 (NID 1) and 1156–1169 (NID 2), respectively
in the N- and C-terminal fragments. TET1
fragments containing deletions of these regions
did not interact with NANOG compared to the
unmutated version (Figure S4(a) and (b)). Full-
length TET1 constructs with deletions in NID 1
(D1), NID 2 (D2) or both (D1+2) were therefore
generated (Figure S4(c)). A TET1 mutant lacking
a low-complexity insert (D1733-1901) was used
as a control (Figure S4(c)), as this region has
been hypothesised to function in protein–protein
interactions.37 As expected, NANOG was co-
6080 The TET1-NANOG interaction in embryonic stem cellsimmunoprecipitated with each of the single TET1
mutants. Surprisingly however, although the TET1
D1+2 double-mutant showed reduced NANOG
binding compared to wild-type, binding was not
completely eliminated (Figure S4(d)). This suggests
that an additional NANOG-interacting domain mayFigure 4. A third NANOG-interacting domain overlapping
itation of (Flag)3-TET1 truncations with (HA)3-NANOG in E14
in an unmutated (WT) Tet1 plasmid (not shown for simplici
mutations (red crosses). (b) Immunoblots were probed with th
n = 3). (c) and (d) Co-immunoprecipitations of (Flag)3-TET1 m
substitution mutants between 1522 and 1547 were prepared
120 + D1132-1202 (D1+2) mutations (red crosses). (d) Immu
left (representative images, n = 2).exist in TET1. To identify this third NID, TET1
expression plasmids were generated combining
the double mutation D1+2 with increasing
C-terminal truncations (Figure 4(a)). Plasmids with
wild-type TET1 coding sequence used as controls
allowed assessment of the relative importance ofTET1 catalytic domain. (a) and (b) Co-immunoprecip-
/T ESCs. (a) TET1 truncations were prepared in parallel
ty) or one carrying the D109-120 + D1132-1202 (D1+2)
e antibodies indicated on the left (representative images,
utants with (HA)3-NANOG from E14/T ESCs. (c) Alanine
in a plasmid expressing TET1(1–1547) with the D109-
noblots were probed with the antibodies indicated on the
6081The TET1-NANOG interaction in embryonic stem cellsNIDs 1 and 2 for NANOG binding. With both wild-
type and double-mutant constructs, the TET1-
NANOG interaction was dramatically impaired
when the TET1 C-terminus was truncated from resi-
due 1547 to 1521 (Figure 4(b)). Smaller fragments
(1–1521, 1–1494, 1–1472 and 1–1379) retained a
weak residual interaction with NANOG, which was
abolished in double mutants (D1+2). These results
mapped a third NANOG-interacting domain within
TET1 to residues 1522–1547 (NID 3). Most of these
residues are strictly conserved in evolution as they
are contained within the cysteine-rich catalytic
domain (Figure S4(e)). To identify the residues
within this region that bind NANOG, a TET1 con-
struct carrying mutations in NIDs 1 and 2 (TET1Figure 5. Generation of a TET1 triple-mutant unable to
indicated full-length (Flag)3-TET1 mutants (a) with (HA)3-NA
with the antibodies indicated on the left (representative ima
was normalised to TET1 immunoprecipitation levels and
independent experiments and error bars standard deviation.D1+2) was further modified by alanine substitution
of serine, positively charged or aromatic residues
within residues 1522–1547 (Figure 4(c)). The aro-
matic?A construct (F1523A, F1525A, W1529A,
Y1532A, F1533A, F1538A, F1547A), but not other
mutants, reduced the NANOG interaction to a sim-
ilar extent as the truncated negative control (TET1
1–1521 D1+2) (Figure 4(d)). These data indicate
that aromatic residues within TET1 1522–1547 play
a critical role for interacting with NANOG in ESCs.
Finally, a full-length TET1 mutant containing muta-
tions in the three NANOG-interacting domains iden-
tified in this study (D109–120 + D1132–1202 +
1522–1547 aromatic?A) was generated and
tested (Figure 5(a)). Interestingly, the sequentialinteract with NANOG. Co-immunoprecipitation of the
NOG from E14/T ESCs. (b) Immunoblots were probed
ges, n = 2). (c) Co-immunoprecipitated NANOG protein
expressed relative to wild-type; data points indicate
6082 The TET1-NANOG interaction in embryonic stem cellsmutations of NIDs 1, 2 and 3 within full-length TET1
gradually decreased the interaction with NANOG,
to a level comparable to the negative control (Fig-
ure 5(b) and (c)).
To identify the NANOG region(s) interacting with
TET1 C-terminus, a series of (HA)3-tagged
NANOG mutants were expressed in ESCs,
together with (Flag)3-TET1 734–2039 (Figure 6
(a)). Strikingly, only the NANOG mutant lacking
the WR region (NANOG DWR) showed a reduced
interaction with the TET1 C-terminus (Figure 6(b)).
To identify residues within WR responsible for
protein–protein interactions, particular amino acids
(tryptophan, asparagine, serine and threonine)
were substituted by alanine within the WR region
of full-length NANOG (Figure 6(c)). Only the
W?A mutant showed a decreased interaction
with the TET1 C-terminus (Figure 6(d)),
demonstrating a key role for tryptophans in the
interaction of NANOG with the Tet1 C-terminus.
However, full-length TET1 retained its interaction
with the W?A mutant (Figure S5), confirming that
other NANOG regions interact with TET1
N-terminus. Together, these experiments
demonstrate that NANOG interacts with the TET1
C-terminus via aromatic residues conserved in
both proteins (Figure 6(e)).
TET1 and NANOG co-bind a subset of
pluripotency enhancers associated with
NANOG transcriptional target genes
Although TET1 and NANOG interact directly in
ESCs, the relationship between the two proteins
on chromatin remains unclear. To identify genomic
sites potentially regulated by the TET1-NANOG
complex, published TET1 and NANOG ChIP-seq
datasets were compared. TET1 ChIP-seq peaks
from two independent datasets23,24 showed an
overlap of 13,279 “high confidence” TET1 binding
sites (Figure S6(a)). A similar analysis of two
NANOG ChIP-seq studies38,39 identified 24,357
“high confidence” NANOG ChIP-seq peaks (Fig-
ure S6(b)). Subsequently, TET1 and NANOG
ChIP-seq signals were visualised at high confi-
dence NANOG and TET1 binding sites, respec-
tively. Interestingly, TET1 is enriched at the centre
of a large proportion of NANOG binding sites in
ESCs, and this signal is abolished upon Tet1 knock-
down (Figure 7(a)). In contrast, NANOG is enriched
only at a small proportion of TET1 binding sites in
ESCs (Figure S6(c)). Consistent with this low level
of co-enrichment, the stringent intersection of “high
confidence” TET1 and NANOG ChIP-seq peaks
identified only 2003 sites bound by both TET1
and NANOG (Figure S6(d) and (e)). As a first
inspection, TET1-NANOG peaks were crossed with
relevant genomic features, showing a large propor-
tion of sites corresponding to ESC enhancers40
(65%) and a smaller proportion overlapping with
CpG islands41 (22%) (Figure 7(b)). Remarkably,
de novo motif analysis identified the SOX2/OCT4composite motif at TET1-NANOG co-bound sites
(Figure 7(c)). Following these observations, further
analyses were performed to characterise genes
associated with TET1-NANOG ChIP-seq peaks.
Gene ontology analysis identified groups of genes
associated with pluripotency among the top cate-
gories, such as “stem cell population maintenance”,
“cellular response to leukemia inhibitory factor” and
“cell fate specification” (Figure S6(f)). Importantly,
TET1-NANOG ChIP-seq peaks were found within
or in proximity to 48% of NANOG transcriptional tar-
get genes42 (Figure 7(d) and Table 1). Visual
inspection of these loci showed enrichment of
TET1 and NANOG ChIP-seq signals at known
enhancers and putative cis-regulatory elements
(Figure S6(g)). Together, these results suggest that
the TET1-NANOG complex regulates a significant
subset of NANOG target genes.Discussion
TET119 and NANOG43,44 are both expressed in
the inner cell mass of the blastocyst, which is mod-
elled in vitro by ESCs. TET1 and NANOG are also
co-expressed in the post-implantation epi-
blast20,45,46 and in developing primordial germ
cells.46,47 Loss of either TET1 or NANOG compro-
mises germline development.48–51 Therefore, the
TET1-NANOG interaction reported here may func-
tion not only at pre-implantation stages but also dur-
ing later development.
Alanine substitution mutagenesis identified
aromatic and hydrophobic residues that mediate
the interaction between TET1 and NANOG.
Tryptophan residues within the NANOG WR
interact with aromatic residues in the TET1 NID
2/3, suggesting an interaction by aromatic
stacking. Tryptophans within the WR are also
critical for NANOG homodimerization and binding
to SOX2 aromatic residues.52,53,30,54 TET1 might
compete with SOX2 for binding to the WR. Alterna-
tively TET1 and other partner proteins, such as
SOX2, could bind simultaneously to different resi-
dues within the WR to form larger protein com-
plexes. The present work also demonstrates a
direct, WR-independent interaction between
NANOG and the TET1 N-terminus, indicative of
novel protein interaction sites in NANOG.
TET1 has previously been reported to interact
with the SIN3A PAH1 domain by amphipathic
helix formation35 and with the O-linked
N-acetylglucosamine transferase (OGT) via
C-terminal TET1 residues.55 However, none of
these TET1 residues overlap with the NANOG-
interacting domains identified in this study. Other
TET1-interacting proteins have been identi-
fied.29,31,32,36,56–58 These include thymine DNA gly-
cosylase, which binds TET1 through at least two
sites.56 However, apart from SIN3A and OGT, the
residues mediating these interactions have not
been defined. The present work demonstrates a
Figure 6. Tryptophan residues within NANOG WR interact with TET1 C-terminus. (a) and (b) Co-immunoprecip-
itations of (Flag)3-TET1 (734–2039) with the indicated (HA)3-NANOG deletion mutants (a) from E14/T ESCs.
(b) Immunoblots were probed with the antibodies indicated on the left (representative images, n = 2). (c) and
(d) Co-immunoprecipitation of (Flag)3-TET1(734–2039) with (HA)3-NANOG or the derivative alanine substitution
mutants within the WR from E14/T ESCs. (c) Only amino acids within NANOG WR region were mutated to alanine.
(d) Immunoblots were probed with the antibodies indicated on the left (representative images, n = 2). (e) Diagram of
the interactions between the TET1 C-terminal domains (NIDs 2 and 3) and NANOG, highlighting aromatic residues
critical for the interaction (red).
6083The TET1-NANOG interaction in embryonic stem cells
Figure 7. Identification of TET1-NANOG co-bound sites on chromatin in ESCs. (a) TET1 and NANOG ChIP-seq
signals at NANOG “high confidence” binding sites, as defined in Figure S6(b). TET1 ChIP-seq in ESCs treated with
Tet1 shRNA (knockdown) was used as a negative control. (b) Pie chart showing the portion of TET1-NANOG co-
bound sites (see Figure S6(d)) overlapping with ESC enhancers and CpG islands. (c) De novo motif analysis
performed on TET1-NANOG co-bound sites, showing the most significant binding motif and its respective E-value. (d)
Pie chart showing the portion of NANOG transcriptional target genes with NANOG or TET1-NANOG co-bound sites.
6084 The TET1-NANOG interaction in embryonic stem cellsdirect physical interaction between TET1 and
NANOG. Strikingly, the TET1-NANOG interaction
involves multiple independent binding regions
between both proteins. The three NANOG-interacting domains on TET1 (residues 109–120,
1156–1169 and 1522–1547) have not been charac-
terised in other protein interaction studies. This
adds new information about TET1 function and
Table 1 NANOG transcriptional target genes associated
with TET1-NANOG co-bound sites.
Activated genes Repressed genes
B4gat1 Ctbp2
Cdc42ep4 Dusp1
Cpsf4l Edn2
En1 Fzd7
Esrrb Hmces
Igf2bp2 Lefty2
Kit Lpar6
Klf4 Nid2
Lmo4 Otx2
Manba Raet1e
Mras Rbm47
Plekhg3 Rbpms
Plpp1 Smagp
Setd1b Socs3
Sp5 Tcf15
Tmem51
6085The TET1-NANOG interaction in embryonic stem cellssuggests that TET1 could also interact with other
proteins through multiple binding sites. NID 1
(TET1 residues 109–120) binds NANOG in
E. coli, indicating that the interaction is independent
of post-translational modifications. However, the
interaction between NID 2 (TET1 residues 1156–
1169) and NANOG could not be demonstrated
using a bacterial expression system. While this
interaction seems to be independent of phosphory-
lation, other modifications like O-GlcNAcylation34,59
might modulate this protein–protein interaction.
Interestingly, NID 3 (TET1 residues 1522–1547)
includes residues that interact with DNA, that lie
adjacent to the TET1 catalytic domain and that
are conserved in TET2 and TET3.60 We have
recently identified two binding regions in TET2 that
interact with NANOG and one of these includes
residues homologous to NID 3.21 Importantly, this
region (TET1 residues 1522–1547) also contains
residues that bind methylated CpG.60 Therefore,
binding of NANOG to NID 3 could modulate the
interaction of the catalytic domain of TET1 with
DNA that depends on these residues. Notably, the
TET1-NANOG interaction seems to be DNA-
independent since the interaction is seen in
DNase-treated protein extracts, and since the inter-
action is unaffected by deletion of the NANOG
homeodomain or the TET1 CXXC domain. It will
therefore be of interest to determine whether the
interaction with NANOG modulates TET1 catalytic
activity.
Here, comparative analysis of TET1 and NANOG
ChIP-seq datasets identified a subset of genomic
loci co-bound by TET1 and NANOG in ESCs that
mainly correspond to pluripotency enhancers. In
contrast to most TET1 binding sites that show a
broad TET1 ChIP signal, TET1 binding at TET1-
NANOG co-bound sites is more narrowly
focussed on NANOG peaks. Further supporting
NANOG-mediated targeting to these loci, de novomotif analysis of these sites identified the SOX2/
OCT4 motif, which characterises NANOG ChIP-
seq peaks in ESCs.61 About half of NANOG target
genes have a TET1-NANOG peak nearby, suggest-
ing that TET1 may act cooperatively with NANOG
to regulate transcription.62 NANOG target genes
that have an associated TET1-NANOG peak
include genes that are either activated or repressed
by NANOG in ESCs. Potentially, TET1 could modu-
late transcription by demethylating enhancer
DNA.18,29,63 Alternatively, TET1 may regulate the
expression of NANOG target genes by recruiting
the SIN3A co-repressor complex at these
loci.23,64,65 However, further investigation will be
required to unravel the mechanisms by which
enhancers may be co-regulated by TET1 and
NANOG and to distinguish action at positively and
negatively regulated NANOG target genes.Materials and Methods
– Molecular cloning
Mouse TET1 open reading frame was subcloned
into pPyCAG plasmids for exogenous expression of
(Flag)3-tagged proteins under a constitutive
promoter in embryonic stem cells (see Cell culture
section).43 TET1 open reading frame was sub-
cloned into pRSFDuet plasmids (Novagen) for
exogenous expression of MBP-tagged proteins
under an IPTG-inducible promoter in E. coli (see
Preparation of protein extracts from bacterial pel-
lets). TET1 truncations and mutants were obtained
by cloning PCR products or synthetic DNA frag-
ments (Integrated DNA Technologies, Inc.) using
Gibson Assembly.66 For more information, please
see our list of plasmid constructs, which are avail-
able upon request.
– Cell culture
E14/T mouse embryonic stem cells were used in
this study, as they constitutively express the
polyoma large T antigen and can therefore
propagate pPyCAG plasmids carrying the
polyoma origin of replication.43 ESCs were cultured
in a 37 C/7% CO2 incubator on gelatin-coated
plates. Composition of the culture medium: Glas-
gow minimum essential medium (Sigma-Aldrich,
cat. G5154), 10% fetal bovine serum, 1 L-
glutamine (Thermo Fisher Scientific, cat.
25030024), 1 sodium pyruvate (Thermo Fisher
Scientific, cat. 11360039), 1 MEM non-essential
amino acids (Thermo Fisher Scientific, cat.
11140035), 0.1 mM 2-Mercaptoethanol (Thermo
Fisher Scientific, cat. 31350010), 100U/ml LIF
(made in-house).
To overexpress tagged proteins for co-
immunoprecipitations, 3  106 E14/T ESCs were
transfected with pPyCAG plasmids of interest
using Lipofectamine 3000 (Thermo Fisher
Scientific, cat. L3000008). Transfections were
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instructions. E14/T ESCs were harvested 24 h after
transfection for protein extract preparation.
– Preparation of nuclear protein extracts from
embryonic stem cells
ESCs were washed twice with PBS, trypsinised
and pelleted (5 min, 400 g, 4 C) before lysis in
swelling buffer (5 mM PIPES pH8.0, 85 mM KCl)
freshly supplemented with 1x protease inhibitor
cocktail (Roche, cat. 04693116001) and 0.5% NP-
40. After 20 min on ice with occasional shaking,
nuclei were pelleted (10 min, 500 g, 4 C) and
resuspended in 1 ml of lysis buffer (20 mM
HEPES pH7.6, 350 mM KCl, 0.2 mM EDTA,
1.5 mM MgCl2, 20% glycerol) freshly
supplemented with 0.2% NP-40, 0.5 mM DTT,
and 1x protease inhibitor cocktail. The material
was transferred into no-stick microtubes (Alpha
Laboratories, cat. LW2410AS) and supplemented
with 150 U/ml of Benzonase nuclease (Millipore,
cat. 71206). Samples were incubated on a
rotating wheel for 30 min at 4 C and centrifuged
(16,000 g, 30 min, 4 C) to remove any
precipitate. Nuclear proteins extracts were stored
at 80 C, or used directly for
immunoprecipitation or immunoblot. 30–50 ml of
protein extract was used as input material and
boiled in Laemmli buffer for 5 min at 95 C.
– Immunopurification of (Flag)3-tagged proteins
from nuclear protein extracts
To immunoprecipitate TET1, 5 mg of anti-Flag
(Sigma-Aldrich, cat. F3165) or anti-TET1
(Millipore, cat. 09–872) antibody was added to
protein extracts. For negative controls, 5 mg of
normal IgG (Santa Cruz) were added to protein
extracts. Samples were incubated overnight at 4 
C on a rotating wheel. 30 ml of beads coupled
with ProteinA or ProteinG (GE Healthcare 4 Fast
Flow Sepharose), previously blocked with 0.5 mg/
ml chicken egg albumin (Sigma-Aldrich), were
added to each sample, followed by a 2 h
incubation at 4 C on a rotating wheel. Beads
were washed 5 times with lysis buffer (20 mM
HEPES pH7.6, 350 mM KCl, 0.2 mM EDTA,
1.5 mM MgCl2, 20% glycerol) freshly
supplemented with 0.5% NP-40 and 0.5 mM DTT.
Between each wash, samples were centrifuged at
4 C for 1 min at 2,000 rpm. After the final wash,
beads were resuspended in Laemmli buffer and
boiled for 5 min at 95 C
As an alternative strategy to immunoprecipitate
(Flag)3-tagged proteins, 30 ml of anti-Flag
magnetic beads (Sigma-Aldrich, cat. M8823) was
added to each protein extract. To
immunoprecipitate endogenous TET1 from Tet1-
(Flag)3 ESCs, 150 ml of anti-Flag magnetic beads
were added to nuclear protein extracts obtained
from 200 million cells, as described above.Samples were incubated on a rotating wheel for
2 h at room temperature. Following three washes
with PBS using a magnet (Thermo Fisher
Scientific, cat. 12321D), magnetic beads were
resuspended in Laemmli buffer and boiled for
5 min at 95 C. Samples were stored at 20 C
or analysed directly by immunoblot.
– Preparation of protein extracts from bacterial
pellets
Chemically competent BL21(DE3) E. coli (NEB,
cat. C2527I) were transformed with pRSF
bacterial expression plasmids of interest. A single
colony was inoculated in LB medium
supplemented with appropriate antibiotics and
incubated overnight in a 37 C shaker (225 rpm).
The overnight culture was diluted (1/50) in a 50 ml
flask containing 50 ml of LB medium
supplemented with appropriate antibiotics and
incubated in a 37 C shaker (225 rpm) until the
culture reached the exponential phase (3 h,
A600: 0.5–0.7). 1 mM IPTG was added to the
culture to initiate protein expression, and cells
were transferred in an 18 C shaker (225 rpm) for
6 h. Bacterial pellets were collected by
centrifugation (5000 g, 10 min) and stored at
20 C until protein extraction.
To prepare protein extracts, bacterial pellets were
resuspended in 5 ml of cold protein extraction buffer
(25 mM Tris–HCl pH 8.0, 200 mM NaCl), and
sonicated 3x1 min on ice. Samples were
centrifuged (16,000 g, 30 min, 4 C) to remove
insoluble material. Bacterial protein extracts were
stored at 4 C or used directly for protein
purification. 30–50 ml of protein extract was used
as input material and boiled in Laemmli buffer for
5 min at 95 C.
– Purification of MBP-tagged proteins from bacte-
rial extracts
To purify MBP-tagged proteins, each bacterial
protein extract was loaded into a gravity flow
column containing 600 ml of amylose resin. The
resin was washed once with cold protein
extraction buffer (25 mM Tris–HCl pH 8.0,
200 mM NaCl) and MBP-tagged proteins were
eluted in 500 ml of cold protein extraction buffer
(25 mM Tris–HCl pH 8.0, 200 mM NaCl)
supplemented with 10 mM Maltose. 50 ml of
eluate was boiled in Laemmli buffer for 5 min at
95 C.
– Immunoblot
Protein samples were loaded into Bolt 10% Bis–
Tris Plus Gels (Thermo Fisher Scientific, cat.
NW00102BOX) with 1 Bolt MOPS SDS running
buffer (Thermo Fisher Scientific, cat. B0001).
10 ml of SeeBlue Plus2 pre-stained protein
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was used to visualize protein molecular weight.
The electrophoresis was performed at 160 V for
1 h. Proteins were transferred overnight at 4 C
onto a nitrocellulose membrane (150 mA constant
current) with transfer buffer (25 mM Tris, 0.21 M
glycine, 10% methanol). The membrane was
blocked for 1 h at room temperature with 10% (w/
v) non-fat skimmed milk dissolved in PBS
supplemented with 0.1% Tween. Then, the
membrane was incubated for 1 h at room
temperature with primary antibodies diluted to the
working concentration in 5% (w/v) non-fat
skimmed milk dissolved in PBS supplemented
with 0.1% Tween. The membrane was washed 3
times with PBS supplemented with 0.1% Tween,
and incubated for 2 h at room temperature with
LI-COR IRDye conjugated secondary antibodies
diluted 1:5,000 in 5% non-fat skimmed milk
dissolved in PBS supplemented with 0.1% Tween.
The membrane was finally washed 3 times with
PBS supplemented with 0.1% Tween and
analysed using the auto-scan function of the LI-
COR Odyssey FC imaging system. Molecular
weights of protein bands were evaluated by visual
comparison with fluorescent protein standards
(SeeBlue Plus2 Pre-stained ladder, Thermo
Fisher Scientific, cat. LC5925; or Chameleon Duo
Pre-stained ladder LI-COR, cat. 928–60000). For
protein quantification, the relevant bands were
quantified using the LI-COR Image Studio
Software.
– AntibodiesAntibody Reference Working
dilution
(immunoblot)Flag Sigma-Aldrich, cat.
F31651:5,000HA Covance, cat. MMS-
101P1:5,000Nanog Bethyl, cat. A300-397A 1:2,000
GST Abcam, cat. ab92 1:2,000
His tag Abcam, cat. ab18184 1:2,000
MBP NEB, cat. E8032S 1:10,000
Anti-mouse
(secondary)
LI-COR, cat. 926-68072 1:5,000Anti-rabbit
(secondary)LI-COR, cat. 926-32213 1:5,000– Protein alignments
To identify evolutionary conserved residues,
TET1 protein sequences from various mammalian
and non-mammalian species were downloaded
from UNIPROT (https://www.uniprot.org/) and
aligned using ESPript (http://espript.ibcp.fr).67– ChIP-seq analysis
ChIP-seq datasets were analysed using the
Galaxy platform (https://usegalaxy.org).68 Details
concerning the bioinformatic workflow are available
at the following address: https://usegalaxy.org/u/
raf4579/w/workflow-chip-seq-1. Raw sequencing
data (FASTQ files) was downloaded from publicly
available databasesNCBI'sGeneExpressionOmni-
bus or ArrayExpress. Quality control was performed
using the software “FastQC” (Babraham Bioinfor-
matics). Samples were filtered to remove contami-
nating adapter sequences and low-quality reads
(cut-off quality score >20.0). Reads were mapped
to the mouse mm9 reference genome using
“Bowtie2” (BAM file output).69 Reads were mapped
only to a unique genomic location (k = 1). ChIP-seq
peaks were called using the software “MACS2”
(BED file output).70 The immunoprecipitated sample
was compared to the genomic input for identifying
statistically significant binding sites (qvalue 0.05).
For the analysis of NANOG ChIP-seq datasets, the
algorithm optimised for “narrow peaks” was used.
For the analysis of TET1 ChIP-seq datasets, the
algorithm optimised for “broad peaks” was used. If
replicates were available, only ChIP-seq peaks
shared between replicates were considered for fur-
ther analyses. Peaks were considered as shared
between datasets when presenting an overlap of at
least 1 bp. To visualise ChIP-seq datasets on a gen-
ome browser, mapped reads (BAM files) from TET1
ChIP-seq with (GSM611195) or without
(GSM611194) Tet1 knockdown, as well as NANOG
ChIP-seq (GSM1082342) were converted into big-
Wig files using “Deeptools”.71 Data was normalised
in “Reads Per Kilobase Million” (RPKM) to allow
the comparison between ChIP-seq datasets. Geno-
mic snapshots were taken using the genome viewer
“IGV”.72 To visualise ChIP-seq datasets as heat-
maps, the software “Deeptools” was used.71 To per-
form de novo motif analysis on ChIP-seq datasets,
the DNA sequences corresponding to each ChIP-
seq peak were extracted (FASTA file output) and
analysed using the “MEME” software.73 Motifs
between 5 and 25 bp, enriched with a E value
<0.05, were identified. These resultswere compared
to known protein motifs in the JASPAR database.74
ChIP-seq peaks were assigned putative target
genes using the “Genomic Regions Enrichment of
Annotations Tool” (GREAT v4.04: http://bejerano.
stanford.edu/great/public/html/index.php) with
default parameters (basal regulatory domain extend-
ing 5 kb upstream and 1 kb downstream from tran-
scription start site, and an extension up to the basal
regulatory domain of the nearest upstream and
down-stream genes within 1 Mb). Gene ontology
analysis from ChIP-seq peaks was performed using
the “Genomic Regions Enrichment of Annotations
Tool” (GREAT v4.04: http://bejerano.stanford.edu/-
great/public/html/index.php).
6088 The TET1-NANOG interaction in embryonic stem cellsAccession numbers
UniProt Knowledgebase (UniProtKB) accession
numbers: E9Q9Y4 (Mouse TET1 protein sequence),
Q80Z64 (Mouse NANOG protein sequence).
NCBI Gene Expression Omnibus accession
numbers: GSE24841 (TET1 ChIP-seq),
GSE26832 (TET1 ChIP-seq), GSE44286
(NANOG ChIP-seq).
ArrayExpress accession numbers: E-MTAB-
1617 (NANOG ChIP-seq).
CRediT authorship contribution
statement
Raphaël Pantier: Conceptualization,
Methodology, Investigation, Writing - original draft,
Writing - review & editing, Visualization. Nicholas
Mullin: Conceptualization, Methodology,
Supervision, Writing - review & editing. Elisa Hall-
Ponsele: Investigation. Ian Chambers:
Conceptualization, Writing - original draft, Writing -
review & editing, Supervision, Project
administration, Funding acquisition.
Acknowledgements
We thank Elisa Barbieri for constructive
comments on the manuscript. We are grateful to
Kristian Helin (University of Copenhagen and
Memorial Sloan Kettering Cancer Center) for
sharing Tet1 expression plasmids. This work was
funded by a UK Medical Research Council Grant
MR/L018497/1 to IC. RP was supported by a UK
Medical Research Council PhD Fellowship.
Declaration of Competing Interest
The authors declare that they have no known
competing financial interests or personal
relationships that could have appeared to
influence the work reported in this paper.
Appendix A. Supplementary material
Supplementary data to this article can be found
online at https://doi.org/10.1016/j.jmb.2020.10.008.
Received 1 July 2020;
Accepted 7 October 2020;
Available online 13 October 2020
Keywords:
protein–protein interactions;
embryonic stem cells;
chromatin;
pluripotency;
enhancersAbbreviations:
DSBH, double stranded beta helix domain; ESC,
embryonic stem cell; NID, NANOG-interacting domain;
OGT, O-linked N-acetylglucosamine transferase; TET, ten-
eleven-translocation; WR, tryptophan-repeatReferences
1. Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala,
H., Brudno, Y., Agarwal, S., Iyer, L.M., et al., (2009).
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine
in mammalian DNA by MLL Partner TET1. Science, 324,
930–935. https://doi.org/10.1126/science.1170116.
2. Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg,
J.A., He, C., Zhang, Y., (2011). Tet proteins can convert 5-
methylcytosine to 5-formylcytosine and 5-carboxylcytosine.
Science, 333, 1300–1303. https://doi.org/
10.1126/science.1210597.
3. Rasmussen, K.D., Helin, K., (2016). Role of TETenzymes in
DNA methylation, development, and cancer. Genes Dev.,
30, 733–750. https://doi.org/10.1101/gad.276568.115.
4. Habibi, E., Brinkman, A.B., Arand, J., Kroeze, L.I., Kerstens,
H.H.D., Matarese, F., Lepikhov, K., Gut, M., et al., (2013).
Whole-genome bisulfite sequencing of two distinct
interconvertible DNA methylomes of mouse embryonic
stem cells. Cell Stem Cell, 13, 360–369. https://doi.org/
10.1016/j.stem.2013.06.002.
5. Ficz, G., Hore, T.A., Santos, F., Lee, H.J., Dean, W., Arand,
J., Krueger, F., Oxley, D., et al., (2013). FGF signaling
inhibition in ESCs drives rapid genome-wide demethylation
to the epigenetic ground state of pluripotency. Cell Stem
Cell, 13, 351–359. https://doi.org/10.1016/j.
stem.2013.06.004.
6. Hackett, J.A., Dietmann, S., Murakami, K., Down, T.A.,
Leitch, H.G., Surani, M.A., (2013). Synergistic mechanisms
of DNA demethylation during transition to ground-state
pluripotency. Stem Cell Rep., 1, 518–531. https://doi.org/
10.1016/j.stemcr.2013.11.010.
7. von Meyenn, F., Iurlaro, M., Habibi, E., Liu, N.Q.,
Salehzadeh-Yazdi, A., Santos, F., Petrini, E., Milagre, I.,
et al., (2016). Impairment of DNA methylation maintenance
is the main cause of global demethylation in naive
embryonic stem cells. Mol. Cell, 62, 848–861. https://doi.
org/10.1016/j.molcel.2016.04.025.
8. Lu, F., Liu, Y., Jiang, L., Yamaguchi, S., Zhang, Y., (2014).
Role of Tet proteins in enhancer activity and telomere
elongation. Genes Dev.,. https://doi.org/
10.1101/gad.248005.114. gad.248005.114.
9. Hon, G.C., Song, C.-X., Du, T., Jin, F., Selvaraj, S., Lee, A.
Y., Yen, C., Ye, Z., et al., (2014). 5mC oxidation by Tet2
modulates enhancer activity and timing of transcriptome
reprogramming during differentiation. Mol. Cell, 56, 286–
297. https://doi.org/10.1016/j.molcel.2014.08.026.
10. Bogdanovic, O., Smits, A.H., de la Calle Mustienes, E.,
Tena, J.J., Ford, E., Williams, R., Senanayake, U., Schultz,
M.D., et al., (2016). Active DNA demethylation at enhancers
during the vertebrate phylotypic period. Nature Genet., 48,
417–426. https://doi.org/10.1038/ng.3522.
11. Rulands, S., Lee, H.J., Clark, S.J., Angermueller, C.,
Smallwood, S.A., Krueger, F., Mohammed, H., Dean, W.,
et al., (2018). Genome-scale oscillations in DNA
6089The TET1-NANOG interaction in embryonic stem cellsmethylation during exit from pluripotency. Cels, 7, 63–76.
e12. https://doi.org/10.1016/j.cels.2018.06.012.
12. Ginno, P.A., Gaidatzis, D., Feldmann, A., Hoerner, L.,
Imanci, D., Burger, L., Zilbermann, F., Peters, A.H.F.M.,
et al., (2020). A genome-scale map of DNA methylation
turnover identifies site-specific dependencies of DNMTand
TET activity. Nature Commun., 11, 2680. https://doi.org/
10.1038/s41467-020-16354-x.
13. Charlton, J., Jung, E.J., Mattei, A.L., Bailly, N., Liao, J.,
Martin, E.J., Giesselmann, P., Brändl, B., et al., (2020).
TETs compete with DNMT3 activity in pluripotent cells at
thousands of methylated somatic enhancers. Nature
Genet.,, 1–9. https://doi.org/10.1038/s41588-020-0639-9.
14. Dawlaty, M.M., Breiling, A., Le, T., Barrasa, M.I., Raddatz,
G., Gao, Q., Powell, B.E., Cheng, A.W., et al., (2014). Loss
of TET enzymes compromises proper differentiation of
embryonic stem cells. Dev. Cell, 29, 102–111. https://doi.
org/10.1016/j.devcel.2014.03.003.
15. Verma, N., Pan, H., Dore, L.C., Shukla, A., Li, Q.V., Pelham-
Webb, B., Teijeiro, V., Gonzalez, F., et al., (2018). TET
proteins safeguard bivalent promoters from de novo
methylation in human embryonic stem cells. Nature
Genet., 50, 83–95. https://doi.org/10.1038/s41588-017-
0002-y.
16. Gao, Y., Chen, J., Li, K., Wu, T., Huang, B., Liu, W., Kou, X.,
Zhang, Y., et al., (2013). Replacement of Oct4 by Tet1
during iPSC induction reveals an important role of DNA
methylation and hydroxymethylation in reprogramming. Cell
Stem Cell, 12, 453–469. https://doi.org/10.1016/j.
stem.2013.02.005.
17. Hu, X., Zhang, L., Mao, S.-Q., Li, Z., Chen, J., Zhang, R.-R.,
Wu, H.-P., Gao, J., et al., (2014). Tet and TDG mediate DNA
demethylation essential for mesenchymal-to-epithelial
transition in somatic cell reprogramming. Cell Stem Cell,
14, 512–522. https://doi.org/10.1016/j.stem.2014.01.001.
18. Sardina, J.L., Collombet, S., Tian, T.V., Gomez, A., Di
Stefano, B., Berenguer, C., Brumbaugh, J., Stadhouders,
R., et al., (2018). Transcription factors drive Tet2-mediated
enhancer demethylation to reprogram cell fate. Cell Stem
Cell, 23, 727–741.e9. https://doi.org/10.1016/j.
stem.2018.08.016.
19. Ito, S., D’Alessio, A.C., Taranova, O.V., Hong, K., Sowers, L.
C., Zhang, Y., (2010). Role of Tet proteins in 5mC to 5hmC
conversion, ES-cell self-renewal and inner cell mass
specification. Nature, 466, 1129–1133. https://doi.org/
10.1038/nature09303.
20. Khoueiry, R., Sohni, A., Thienpont, B., Luo, X., Velde, J.V.,
Bartoccetti, M., Boeckx, B., Zwijsen, A., et al., (2017).
Lineage-specific functions of TET1 in the postimplantation
mouse embryo. Nature Genet., 49, 1061–1072. https://doi.
org/10.1038/ng.3868.
21. Pantier, R., Tatar, T., Colby, D., Chambers, I., (2019).
Endogenous epitope-tagging of Tet1, Tet2 and Tet3
identifies TET2 as a naïve pluripotency marker. Life Sci.
Alliance, 2, e201900516. https://doi.org/10.26508/
lsa.201900516.
22. Zhang, H., Zhang, X., Clark, E., Mulcahey, M., Huang, S.,
Shi, Y.G., (2010). TET1 is a DNA-binding protein that
modulates DNA methylation and gene transcription via
hydroxylation of 5-methylcytosine. Cell Res., 20, 1390–
1393. https://doi.org/10.1038/cr.2010.156.
23. Williams, K., Christensen, J., Pedersen, M.T., Johansen, J.
V., Cloos, P.A.C., Rappsilber, J., Helin, K., (2011). TET1 and
hydroxymethylcytosine in transcription and DNAmethylation fidelity. Nature, 473, 343–348. https://doi.org/
10.1038/nature10066.
24. Wu, H., D’Alessio, A.C., Ito, S., Xia, K., Wang, Z., Cui, K.,
Zhao, K., Eve Sun, Y., et al., (2011). Dual functions of Tet1
in transcriptional regulation in mouse embryonic stem cells.
Nature, 473, 389–393. https://doi.org/
10.1038/nature09934.
25. Xu, Y., Wu, F., Tan, L., Kong, L., Xiong, L., Deng, J.,
Barbera, A.J., Zheng, L., et al., (2011). Genome-wide
regulation of 5hmC, 5mC, and gene expression by Tet1
hydroxylase in mouse embryonic stem cells. Mol. Cell, 42,
451–464. https://doi.org/10.1016/j.molcel.2011.04.005.
26. Xiong, J., Zhang, Z., Chen, J., Huang, H., Xu, Y., Ding, X.,
Zheng, Y., Nishinakamura, R., et al., (2016). Cooperative
action between SALL4A and TET proteins in stepwise
oxidation of 5-methylcytosine. Mol. Cell, 64, 913–925.
https://doi.org/10.1016/j.molcel.2016.10.013.
27. de la Rica, L., Deniz, Ö., Cheng, K.C.L., Todd, C.D., Cruz,
C., Houseley, J., Branco, M.R., (2016). TET-dependent
regulation of retrotransposable elements in mouse
embryonic stem cells. Genome Biol., 17, 234. https://doi.
org/10.1186/s13059-016-1096-8.
28. Ravichandran, M., Lei, R., Tang, Q., Zhao, Y., Lee, J., Ma,
L., Chrysanthou, S., Lorton, B.M., et al., (2019). Rinf
regulates pluripotency network genes and Tet enzymes in
embryonic stem cells. Cell Rep., 28, 1993–2003.e5. https://
doi.org/10.1016/j.celrep.2019.07.080.
29. Costa, Y., Ding, J., Theunissen, T.W., Faiola, F., Hore, T.A.,
Shliaha, P.V., Fidalgo, M., Saunders, A., et al., (2013).
NANOG-dependent function of TET1 and TET2 in
establishment of pluripotency. Nature, 495, 370–374.
https://doi.org/10.1038/nature11925.
30. Gagliardi, A., Mullin, N.P., Ying Tan, Z., Colby, D., Kousa, A.
I., Halbritter, F., Weiss, J.T., Felker, A., et al., (2013). A direct
physical interaction between Nanog and Sox2 regulates
embryonic stem cell self-renewal. EMBO J., 32, 2231–
2247. https://doi.org/10.1038/emboj.2013.161.
31. Zhu, G., Li, Y., Zhu, F., Wang, T., Jin, W., Mu, W., Lin,
W., Tan, W., et al., (2014). Coordination of engineered
factors with TET1/2 promotes early-stage epigenetic
modification during somatic cell reprogramming. Stem
Cell Rep., 2, 253–261. https://doi.org/10.1016/j.
stemcr.2014.01.012.
32. Okashita, N., Kumaki, Y., Ebi, K., Nishi, M., Okamoto, Y.,
Nakayama, M., Hashimoto, S., Nakamura, T., et al., (2014).
PRDM14 promotes active DNA demethylation through the
Ten-eleven translocation (TET)-mediated base excision
repair pathway in embryonic stem cells. Development,
141, 269–280. https://doi.org/10.1242/dev.099622.
33. Zhang, W., Xia, W., Wang, Q., Towers, A.J., Chen, J., Gao,
R., Zhang, Y., Yen, C., et al., (2016). Isoform switch of TET1
regulates DNA demethylation and mouse development.
Mol. Cell, 64, 1062–1073. https://doi.org/10.1016/
j.molcel.2016.10.030.
34. Shi, F.-T., Kim, H., Lu, W., He, Q., Liu, D., Goodell, M.A.,
Wan, M., Songyang, Z., (2013). Ten-Eleven Translocation 1
(Tet1) is regulated by O-linked N-acetylglucosamine
transferase (Ogt) for target gene repression in mouse
embryonic stem cells. J. Biol. Chem., 288, 20776–20784.
https://doi.org/10.1074/jbc.M113.460386.
35. Chandru, A., Bate, N., Vuister, G.W., Cowley, S.M., (2018).
Sin3A recruits Tet1 to the PAH1 domain via a highly
conserved Sin3-Interaction Domain. Sci. Rep., 8, 14689.
https://doi.org/10.1038/s41598-018-32942-w.
6090 The TET1-NANOG interaction in embryonic stem cells36. Li, W., Karwacki-Neisius, V., Ma, C., Tan, L., Shi, Y., Wu, F.,
Shi, Y.G., (2020). Nono deficiency compromises TET1
chromatin association and impedes neuronal differentiation
of mouse embryonic stem cells. Nucleic Acids Res.,,
gkaa213. https://doi.org/10.1093/nar/gkaa213.
37. Pastor, W.A., Aravind, L., Rao, A., (2013). TETonic shift:
biological roles of TET proteins in DNA demethylation and
transcription. Nature Rev. Mol. Cell Biol., 14, 341–356.
https://doi.org/10.1038/nrm3589.
38. Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin,
C.Y., Kagey, M.H., Rahl, P.B., Lee, T.I., et al., (2013). Master
transcription factors and mediator establish super-
enhancers at key cell identity genes. Cell, 153, 307–319.
https://doi.org/10.1016/j.cell.2013.03.035.
39. Karwacki-Neisius, V., Göke, J., Osorno, R., Halbritter, F.,
Ng, J.H., Weiße, A.Y., Wong, F.C.K., Gagliardi, A., et al.,
(2013). Reduced Oct4 expression directs a robust
pluripotent state with distinct signaling activity and
increased enhancer occupancy by Oct4 and Nanog. Cell
Stem Cell, 12, 531–545. https://doi.org/10.1016/j.
stem.2013.04.023.
40. Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-Andre, V.,
Sigova, A.A., Hoke, H.A., Young, R.A., (2013). Super-
enhancers in the control of cell identity and disease. Cell,
155, 934–947. https://doi.org/10.1016/j.cell.2013.09.053.
41. Illingworth, R.S., Gruenewald-Schneider, U., Webb, S.,
Kerr, A.R.W., James, K.D., Turner, D.J., Smith, C.,
Harrison, D.J., et al., (2010). Orphan CpG islands identify
numerous conserved promoters in the mammalian
genome. PLoS Genet., 6, e1001134. https://doi.org/
10.1371/journal.pgen.1001134.
42. Festuccia, N., Osorno, R., Halbritter, F., Karwacki-Neisius,
V., Navarro, P., Colby, D., Wong, F., Yates, A., et al., (2012).
Esrrb is a direct Nanog target gene that can substitute for
Nanog function in pluripotent cells. Cell Stem Cell, 11, 477–
490. https://doi.org/10.1016/j.stem.2012.08.002.
43. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S.,
Tweedie, S., Smith, A., (2003). Functional expression
cloning of Nanog, a pluripotency sustaining factor in
embryonic stem cells. Cell, 113, 643–655. https://doi.org/
10.1016/S0092-8674(03)00392-1.
44. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami,
M., Takahashi, K., Maruyama, M., Maeda, M., Yamanaka,
S., (2003). The homeoprotein NANOG is required for
maintenance of pluripotency in mouse epiblast and ES
cells. Cell, 113, 631–642. https://doi.org/10.1016/S0092-
8674(03)00393-3.
45. Hart, A.H., Hartley, L., Ibrahim, M., Robb, L., (2004).
Identification, cloning and expression analysis of the
pluripotency promoting Nanog genes in mouse and
human. Dev. Dyn., 230, 187–198. https://doi.org/10.1002/
dvdy.20034.
46. Yamaguchi, S., Kimura, H., Tada, M., Nakatsuji, N., Tada, T.,
(2005). Nanog expression in mouse germ cell development.
Gene Expr. Patterns, 5, 639–646. https://doi.org/10.1016/
j.modgep.2005.03.001.
47. Yamaguchi, S., Hong, K., Liu, R., Shen, L., Inoue, A., Diep,
D., Zhang, K., Zhang, Y., (2012). Tet1 controls meiosis by
regulating meiotic gene expression. Nature, 492, 443–447.
https://doi.org/10.1038/nature11709.
48. Yamaguchi, S., Shen, L., Liu, Y., Sendler, D., Zhang, Y.,
(2013). Role of Tet1 in erasure of genomic imprinting.
Nature, 504, 460–464. https://doi.org/
10.1038/nature12805.49. Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B.,
Robertson, M., Vrana, J., Jones, K., et al., (2007). Nanog
safeguards pluripotency and mediates germline
development. Nature, 450, 1230–1234. https://doi.org/
10.1038/nature06403.
50. Yamaguchi, S., Kurimoto, K., Yabuta, Y., Sasaki, H.,
Nakatsuji, N., Saitou, M., Tada, T., (2009). Conditional
knockdown of Nanog induces apoptotic cell death in mouse
migrating primordial germ cells. Development, 136, 4011–
4020. https://doi.org/10.1242/dev.041160.
51. Zhang, M., Leitch, H.G., Tang, W.W.C., Festuccia, N., Hall-
Ponsele, E., Nichols, J., Surani, M.A., Smith, A., et al.,
(2018). Esrrb complementation rescues development of
Nanog-null germ cells. Cell Rep., 22, 332–339. https://doi.
org/10.1016/j.celrep.2017.12.060.
52. Wang, J., Levasseur, D.N., Orkin, S.H., (2008).
Requirement of Nanog dimerization for stem cell self-
renewal and pluripotency. PNAS, 105, 6326–6331. https://
doi.org/10.1073/pnas.0802288105.
53. Mullin, N.P., Yates, A., Rowe, A.J., Nijmeijer, B., Colby, D.,
Barlow, P.N., Walkinshaw, M.D., Chambers, I., (2008). The
pluripotency rheostat Nanog functions as a dimer.
Biochem. J, 411, 227. https://doi.org/10.1042/BJ20080134.
54. Mullin, N.P., Gagliardi, A., Khoa, L.T.P., Colby, D., Hall-
Ponsele, E., Rowe, A.J., Chambers, I., (2017). Distinct
contributions of tryptophan residues within the dimerization
domain to Nanog function. J. Mol. Biol., 429, 1544–1553.
https://doi.org/10.1016/j.jmb.2016.12.001.
55. Hrit, J., Goodrich, L., Li, C., Wang, B.-A., Nie, J., Cui, X.,
Martin, E.A., Simental, E., et al., (2018). OGT binds a
conserved C-terminal domain of TET1 to regulate TET1
activity and function in development. ELife, 7, e34870.
https://doi.org/10.7554/eLife.34870.
56. Weber, A.R., Krawczyk, C., Robertson, A.B., Kusnierczyk,
A., Vågbø, C.B., Schuermann, D., Klungland, A., Schär, P.,
(2016). Biochemical reconstitution of TET1-TDG-BER-
dependent active DNA demethylation reveals a highly
coordinated mechanism. Nature Commun., 7, 10806.
https://doi.org/10.1038/ncomms10806.
57. Sun, Z., Xu, X., He, J., Murray, A., Sun, M., Wei, X., Wang,
X., McCoig, E., et al., (2019). EGR1 recruits TET1 to shape
the brain methylome during development and upon
neuronal activity. Nature Commun., 10, 1–12. https://doi.
org/10.1038/s41467-019-11905-3.
58. Zeng, Y., Yao, B., Shin, J., Lin, L., Kim, N., Song, Q., Liu, S.,
Su, Y., et al., (2016). Lin28A binds active promoters and
recruits Tet1 to regulate gene expression. Mol. Cell, 61,
153–160. https://doi.org/10.1016/j.molcel.2015.11.020.
59. Vella, P., Scelfo, A., Jammula, S., Chiacchiera, F., Williams,
K., Cuomo, A., Roberto, A., Christensen, J., et al., (2013).
Tet proteins connect the O-linked N-acetylglucosamine
transferase Ogt to chromatin in embryonic stem cells.
Mol. Cell, 49, 645–656. https://doi.org/10.1016/
j.molcel.2012.12.019.
60. Hu, L., Li, Z., Cheng, J., Rao, Q., Gong,W., Liu, M., Shi, Y.G.,
Zhu,J.,etal., (2013).CrystalstructureofTET2-DNAcomplex:
Insight into TET-mediated 5mC oxidation. Cell, 155, 1545–
1555. https://doi.org/10.1016/j.cell.2013.11.020.
61. Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V.B.,
Wong, E., Orlov, Y.L., et al., (2008). Integration of external
signaling pathways with the core transcriptional network in
embryonic stem cells. Cell, 133, 1106–1117. https://doi.org/
10.1016/j.cell.2008.04.043.
6091The TET1-NANOG interaction in embryonic stem cells62. Festuccia, N., Osorno, R., Wilson, V., Chambers, I., (2013).
The role of pluripotency gene regulatory network
components in mediating transitions between pluripotent
cell states. Curr. Opin. Genet. Dev., 23, 504–511. https://
doi.org/10.1016/j.gde.2013.06.003.
63. Wang, L., Ozark, P.A., Smith, E.R., Zhao, Z., Marshall, S.A.,
Rendleman, E.J., Piunti, A., Ryan, C., et al., (2018). TET2
coactivates gene expression through demethylation of
enhancers. Sci. Adv., 4, eaau6986. https://doi.org/
10.1126/sciadv.aau6986.
64. Zhu, F., Zhu, Q., Ye, D., Zhang, Q., Yang, Y., Guo, X., Liu, Z.,
Jiapaer, Z., et al., (2018). Sin3a–Tet1 interaction activates
gene transcription and is required for embryonic stem cell
pluripotency. Nucleic Acids Res., 46, 6026–6040. https://
doi.org/10.1093/nar/gky347.
65. Saunders, A., Huang, X., Fidalgo, M., Reimer, M.H., Faiola,
F., Ding, J., Sanchez-Priego, C., Guallar, D., et al., (2017).
The SIN3A/HDAC corepressor complex functionally
cooperates with NANOG to promote pluripotency. Cell
Rep., 18, 1713–1726. https://doi.org/10.1016/j.
celrep.2017.01.055.
66. Gibson, D.G., Young, L., Chuang, R.-Y., Venter, J.C.,
Hutchison, C.A., Smith, H.O., (2009). Enzymatic assembly
of DNA molecules up to several hundred kilobases. Nature
Methods, 6, 343–345. https://doi.org/10.1038/nmeth.1318.
67. Robert, X., Gouet, P., (2014). Deciphering key features in
protein structures with the new ENDscript server. Nucleic
Acids Res., 42, W320–W324. https://doi.org/10.1093/nar/
gku316.
68. Afgan, E., Baker, D., van den Beek, M., Blankenberg, D.,
Bouvier, D., Čech, M., Chilton, J., Clements, D., et al., (2016).The Galaxy platform for accessible, reproducible and
collaborative biomedical analyses: 2016 update. Nucleic
Acids Res., 44 (2016), W3–W10. https://doi.org/
10.1093/nar/gkw343.
69. Langmead, B., Salzberg, S.L., (2012). Fast gapped-read
alignment with Bowtie 2. Nature Meth., 9, 357–359. https://
doi.org/10.1038/nmeth.1923.
70. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.
S., Bernstein, B.E., Nusbaum, C., Myers, R.M., et al.,
(2008). Model-based analysis of ChIP-Seq (MACS).
Genome Biol., 9, R137. https://doi.org/10.1186/gb-2008-9-
9-r137.
71. Ramı́rez, F., Ryan, D.P., Grüning, B., Bhardwaj, V., Kilpert,
F., Richter, A.S., Heyne, S., Dündar, F., et al., (2016).
deepTools2: a next generation web server for deep-
sequencing data analysis. Nucleic Acids Res., 44, W160–
W165. https://doi.org/10.1093/nar/gkw257.
72. Robinson, J.T., Thorvaldsdottir, H., Winckler, W., Guttman,
M., Lander, E.S., Getz, G., Mesirov, J.P., (2011). Integrative
genomics viewer. Nature Biotech., 29, 24–26. https://doi.
org/10.1038/nbt.1754.
73. Bailey, T.L., Boden, M., Buske, F.A., Frith, M., Grant, C.E.,
Clementi, L., Ren, J., Li, W.W., et al., (2009). tools for motif
discovery and searching. Nucleic Acids Res., 37, W202–
W208. https://doi.org/10.1093/nar/gkp335.
74. Mathelier, A., Fornes, O., Arenillas, D.J., Chen, C., Denay,
G., Lee, J., Shi, W., Shyr, C., et al., (2016). JASPAR 2016: a
major expansion and update of the open-access database
of transcription factor binding profiles. Nucleic Acids Res.,
44 (2016), D110–D115. https://doi.org/10.1093/nar/
gkv1176.
